What Key Growth Drivers Are Shaping The Pulmonary Or Respiratory Drug Delivery Market Forecast Toward $105.32 Billion?
Claim 30% Off Global Market Reports With Code ONLINE30 – Insights on Tariff Effects, Global Trade, and Industry Disruptors
How Will The Pulmonary Or Respiratory Drug Delivery Market Valuation Change Between Now And 2029?
The market for pulmonary or respiratory drug delivery has seen a robust growth in the recent past. The market value, which is projected to be $69.83 billion in 2024, is expected to increase to $75.67 billion in 2025, with a compound annual growth rate (CAGR) of 8.4%. The historical growth trend is mainly due to an increased incidence of asthma, the use of more sophisticated inhalation devices, a global surge in healthcare spending, heightened awareness about respiratory ailments, and a growing occurrence of allergic conditions.
The market size of pulmonary or respiratory drug delivery is predicted to witness robust expansion in the coming years. It is set to reach “$105.32 billion by 2029, with a compound annual growth rate (CAGR) of 8.6%. This surge during the projected period can be ascribed to factors like the escalating demand for individualized medication, the increasing instances of chronic respiratory conditions, intensifying focus on telemedicine, augmented investments in the healthcare sector’s infrastructure, and the expansion of e-commerce for pharmaceutical items. The forecast period will also see major trends such as advancements in particle engineering, the creation of advanced nebulizers, the evolution of liposomal formulations, progressions in computational fluid dynamics, and the establishment of smart inhalers.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20939&type=smp
Which Factors Are Steering Growth In The Pulmonary Or Respiratory Drug Delivery Market?
The escalating occurrence of pneumonia is projected to fuel the expansion of the pulmonary or respiratory drug delivery market in the future. Pneumonia, a lung affliction, results in the inflammation of air sacs and these can then be filled with fluid or pus, which can lead to symptoms such as coughing, fever, and difficulty in breathing. The uptick in pneumonia cases can be attributed to factors such as elderly populations, diminished immune systems, respiratory infections, air pollution, smoking, and the prevalence of bacteria resistant to antibiotics. Pulmonary or respiratory drug delivery aids individuals with pneumonia by directly focusing medicine, like antibiotics, bronchodilators, or anti-inflammatory agents, on the lungs. This results in a quicker and more potent treatment that can relieve symptoms, decrease inflammation, get rid of infections, and enhance respiratory functionality, all of which can augment recovery and inhibit complications. For illustration, as reported by the Centre for Tropical Medicine and Global Health, a prominent health research institution based in the UK, there was a significant growth in pneumonia cases in Kenya, which climbed up to 793,864 in 2022/2023 during November 2023. Consequently, the growth in pneumonia cases propels the pulmonary or respiratory drug delivery market.
Which Segments Define The Structure Of The Pulmonary Or Respiratory Drug Delivery Market?
The pulmonary or respiratory drug delivery market covered in this report is segmented –
1) By Product: Formulation Type, Device Type
2) By Canister Type: Plain Canister, Coated Canister
3) By Application: Chronic Obstructive Pulmonary Disease, Asthma, Cystic Fibrosis, Other Applications
4) By End-User: Hospitals, Clinics, Home Care Settings
Subsegments:
1) By Formulation Type: Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs), Nebulizers, Liquid Aerosols, Nasal Sprays
2) By Device Type: Inhalers (Manual and Digital), Nebulizers (Compressor, Ultrasonic, Mesh), Breath-Activated Devices, Spacer Devices, Nasal Drug Delivery Devices
What Strategic Shifts And Innovations Are Influencing The Pulmonary Or Respiratory Drug Delivery Market?
Leading organizations in the pulmonary or respiratory drug delivery market are prioritizing advancements in technology, such as complex drug delivery systems, to boost the effectiveness of treatments and patient compliance. These systems are cutting-edge technologies designed to enhance the targeted provision and controlled release of therapeutic agents, leading to improved drug efficacy and patient outcomes. For example, in July 2023, U.S. healthcare company Viatris Inc., which produces generic and branded medicines, along with Kindeva Drug Delivery L.P., a US company specializing in drug delivery, introduced Breyna Inhalation Aerosol. Approved by the Food and Drug Administration, a U.S. government agency, this inhalation aerosol is the first generic version of AstraZeneca’s Symbicort. It’s a metered-dose inhaler that integrates budesonide and formoterol for the treatment of asthma and chronic obstructive pulmonary disease. Breyna is available in concentrations of 80 and 160 micrograms, combined with 4.5 micrograms of formoterol.
Who Are The Global Leaders Steering The Pulmonary Or Respiratory Drug Delivery Market Forward?
Major companies operating in the pulmonary or respiratory drug delivery market are Merck & Co. Inc., Novartis AG, Thermo Fisher Scientific Inc., AstraZeneca plc, Abbott Laboratories, 3M Company, Koninklijke Philips N.V., GlaxoSmithKline, Omron Corporation, Teva Pharmaceutical Industries Ltd., Aptar Pharma, Sumitomo Pharma America Inc., Chiesi Farmaceutici S.p.A., Cipla Inc., Boehringer Ingelheim GmbH, Kindeva Drug Delivery Limited, Nemera Group, Hovione, H And T Presspart Group, Vectura Group plc
Access The Complete Report Here:
What Regional Factors Are Accelerating Growth In The Pulmonary Or Respiratory Drug Delivery Market?
North America was the largest region in the pulmonary or respiratory drug delivery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pulmonary or respiratory drug delivery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=20939&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
